Literature DB >> 19457369

Reducing between scanner differences in multi-center PET studies.

Aniket Joshi1, Robert A Koeppe, Jeffrey A Fessler.   

Abstract

This work is part of the multi-center Alzheimer's Disease Neuroimaging Initiative (ADNI), a large multi-site study of dementia, including patients having mild cognitive impairment (MCI), probable Alzheimer's disease (AD), as well as healthy elderly controls. A major portion of ADNI involves the use of [(18)F]-fluorodeoxyglucose (FDG) with positron emission tomography (PET). The objective of this paper is the reduction of inter-scanner differences in the FDG-PET scans obtained from the 50 participating PET centers having fifteen different scanner models. In spite of a standardized imaging protocol, systematic inter-scanner variability in PET images from various sites is observed primarily due to differences in scanner resolution, reconstruction techniques, and different implementations of scatter and attenuation corrections. Two correction steps were developed by comparison of 3-D Hoffman brain phantom scans with the 'gold standard' digital 3-D Hoffman brain phantom: i) high frequency correction; where a smoothing kernel for each scanner model was estimated to smooth all images to a common resolution and ii) low frequency correction; where smooth affine correction factors were obtained to reduce the attenuation and scatter correction errors. For the phantom data, the high frequency correction reduced the variability by 20%-50% and the low frequency correction further reduced the differences by another 20%-25%. Correction factors obtained from phantom studies were applied to 95 scans from normal control subjects obtained from the participating sites. The high frequency correction reduced differences similar to the phantom studies. However, the low frequency correction did not further reduce differences; hence further refinement of the procedure is necessary.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19457369      PMCID: PMC4308413          DOI: 10.1016/j.neuroimage.2009.01.057

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  4 in total

Review 1.  A probabilistic atlas of the human brain: theory and rationale for its development. The International Consortium for Brain Mapping (ICBM).

Authors:  J C Mazziotta; A W Toga; A Evans; P Fox; J Lancaster
Journal:  Neuroimage       Date:  1995-06       Impact factor: 6.556

2.  Stereotactic PET atlas of the human brain: aid for visual interpretation of functional brain images.

Authors:  S Minoshima; R A Koeppe; K A Frey; M Ishihara; D E Kuhl
Journal:  J Nucl Med       Date:  1994-06       Impact factor: 10.057

3.  Anatomic standardization: linear scaling and nonlinear warping of functional brain images.

Authors:  S Minoshima; R A Koeppe; K A Frey; D E Kuhl
Journal:  J Nucl Med       Date:  1994-09       Impact factor: 10.057

4.  AIDA: an adaptive image deconvolution algorithm with application to multi-frame and three-dimensional data.

Authors:  Erik F Y Hom; Franck Marchis; Timothy K Lee; Sebastian Haase; David A Agard; John W Sedat
Journal:  J Opt Soc Am A Opt Image Sci Vis       Date:  2007-06       Impact factor: 2.129

  4 in total
  91 in total

1.  The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core.

Authors:  William J Jagust; Dan Bandy; Kewei Chen; Norman L Foster; Susan M Landau; Chester A Mathis; Julie C Price; Eric M Reiman; Daniel Skovronsky; Robert A Koeppe
Journal:  Alzheimers Dement       Date:  2010-05       Impact factor: 21.566

2.  The informatics core of the Alzheimer's Disease Neuroimaging Initiative.

Authors:  Arthur W Toga; Karen L Crawford
Journal:  Alzheimers Dement       Date:  2010-05       Impact factor: 21.566

Review 3.  The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Enchi Liu; John C Morris; Ronald C Petersen; Andrew J Saykin; Mark E Schmidt; Leslie Shaw; Judith A Siuciak; Holly Soares; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2011-11-02       Impact factor: 21.566

4.  Correlation of early-phase 18F-florbetapir (AV-45/Amyvid) PET images to FDG images: preliminary studies.

Authors:  Ing-Tsung Hsiao; Chin-Chang Huang; Chia-Ju Hsieh; Wen-Chun Hsu; Shiaw-Pyng Wey; Tzu-Chen Yen; Mei-Ping Kung; Kun-Ju Lin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-01-21       Impact factor: 9.236

5.  Neuroprotective pathways: lifestyle activity, brain pathology, and cognition in cognitively normal older adults.

Authors:  Miranka Wirth; Claudia M Haase; Sylvia Villeneuve; Jacob Vogel; William J Jagust
Journal:  Neurobiol Aging       Date:  2014-02-20       Impact factor: 4.673

6.  Brain imaging of cognitively normal individuals with 2 parents affected by late-onset AD.

Authors:  Lisa Mosconi; John Murray; Wai H Tsui; Yi Li; Nicole Spector; Alexander Goldowsky; Schantel Williams; Ricardo Osorio; Pauline McHugh; Lidia Glodzik; Shankar Vallabhajosula; Mony J de Leon
Journal:  Neurology       Date:  2014-02-12       Impact factor: 9.910

7.  Partial volume correction in quantitative amyloid imaging.

Authors:  Yi Su; Tyler M Blazey; Abraham Z Snyder; Marcus E Raichle; Daniel S Marcus; Beau M Ances; Randall J Bateman; Nigel J Cairns; Patricia Aldea; Lisa Cash; Jon J Christensen; Karl Friedrichsen; Russ C Hornbeck; Angela M Farrar; Christopher J Owen; Richard Mayeux; Adam M Brickman; William Klunk; Julie C Price; Paul M Thompson; Bernadino Ghetti; Andrew J Saykin; Reisa A Sperling; Keith A Johnson; Peter R Schofield; Virginia Buckles; John C Morris; Tammie L S Benzinger
Journal:  Neuroimage       Date:  2014-12-05       Impact factor: 6.556

8.  Nonlinear Distributional Mapping (NoDiM) for harmonization across amyloid-PET radiotracers.

Authors:  Michael J Properzi; Rachel F Buckley; Jasmeer P Chhatwal; Michael C Donohue; Cristina Lois; Elizabeth C Mormino; Keith A Johnson; Reisa A Sperling; Aaron P Schultz
Journal:  Neuroimage       Date:  2018-11-17       Impact factor: 6.556

9.  Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloid.

Authors:  Susan M Landau; Ming Lu; Abhinay D Joshi; Michael Pontecorvo; Mark A Mintun; John Q Trojanowski; Leslie M Shaw; William J Jagust
Journal:  Ann Neurol       Date:  2013-12       Impact factor: 10.422

10.  Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not β-amyloid in cognitively normal older individuals.

Authors:  Miranka Wirth; Cindee M Madison; Gil D Rabinovici; Hwamee Oh; Susan M Landau; William J Jagust
Journal:  J Neurosci       Date:  2013-03-27       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.